AKT1 and neoplasm: Mechanistically, EGCG modulates AR-regulated microRNAs, downregulating oncogenic miRNA-21 while upregulating tumor-suppressive miRNA-330, which modulates the AKT/P-AKT/caspase-3/MMP-2/MMP-9 signaling axis [31,85].